Wilson Sonsini Goodrich & Rosati advised Flame Biosciences on the deal. Flame Biosciences, a clinical-stage biopharmaceutical company developing antibodies to treat cancer and inflammatory diseases, announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
